SABS SCHEDULE 13G/A: SEC filing
Vivo Opportunity Fund Holdings, L.P. and affiliated entities
Filed with the SEC on · accession 0001213900-26-120155
SABS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed an amended Schedule 13G disclosing beneficial ownership of approximately 22,287,501 shares of SAB Biotherapeutics common stock on an as-converted basis, representing 9.99% of the class, subject to blocking provisions. The stock moved +1.4% by the first close after the filing.
Summary of the filing
Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed an amended Schedule 13G disclosing beneficial ownership of approximately 22,287,501 shares of SAB Biotherapeutics common stock on an as-converted basis, representing 9.99% of the class, subject to blocking provisions. The holdings include common stock, Series B Preferred Stock, and warrants convertible within 60 days.
Key details
How SABS stock reacted
Close before
$2.96
Nov 13, 2026
First close after
+1.35%
$3.00
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SABS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SABS?
Click hereFrequently asked questions
What did SABS file with the SEC on Nov 16, 2026?
SABS filed a SCHEDULE 13G/A (SEC filing). Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed an amended Schedule 13G disclosing beneficial ownership of approximately 22,287,501 shares of SAB Biotherapeutics common stock on an as-converted basis, representing 9.99% of the class, subject to blocking provisions. The holdings include common stock, Series B Preferred Stock, and warrants convertible within 60 days.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did SABS stock react to this filing?
SABS closed at $2.96 before the filing and $3.00 on Nov 16, 2026 (+1.35%).
Other SABS SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingOct 13, 2026
- 424B3 · Secondary offeringAug 21, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
Get alerts when SABS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days